Entropy-based adaptive nuclear texture features are independent prognostic markers in a total population of uterine sarcomas

Cytometry A. 2015 Apr;87(4):315-25. doi: 10.1002/cyto.a.22601. Epub 2014 Dec 5.


Nuclear texture analysis measures the spatial arrangement of the pixel gray levels in a digitized microscopic nuclear image and is a promising quantitative tool for prognosis of cancer. The aim of this study was to evaluate the prognostic value of entropy-based adaptive nuclear texture features in a total population of 354 uterine sarcomas. Isolated nuclei (monolayers) were prepared from 50 µm tissue sections and stained with Feulgen-Schiff. Local gray level entropy was measured within small windows of each nuclear image and stored in gray level entropy matrices, and two superior adaptive texture features were calculated from each matrix. The 5-year crude survival was significantly higher (P < 0.001) for patients with high texture feature values (72%) than for patients with low feature values (36%). When combining DNA ploidy classification (diploid/nondiploid) and texture (high/low feature value), the patients could be stratified into three risk groups with 5-year crude survival of 77, 57, and 34% (Hazard Ratios (HR) of 1, 2.3, and 4.1, P < 0.001). Entropy-based adaptive nuclear texture was an independent prognostic marker for crude survival in multivariate analysis including relevant clinicopathological features (HR = 2.1, P = 0.001), and should therefore be considered as a potential prognostic marker in uterine sarcomas.

Keywords: adaptive features; endometrial stromal sarcoma; entropy; leiomyosarcoma; nuclear texture analysis; nucleotyping; prognostic markers; uterine sarcomas.

MeSH terms

  • Algorithms
  • Biomarkers, Tumor / analysis*
  • Cell Nucleus / physiology*
  • Entropy
  • Female
  • Humans
  • Image Processing, Computer-Assisted
  • Leiomyosarcoma / mortality*
  • Leiomyosarcoma / pathology
  • Multivariate Analysis
  • Prognosis
  • Retrospective Studies
  • Sarcoma, Endometrial Stromal / mortality*
  • Sarcoma, Endometrial Stromal / pathology
  • Staining and Labeling
  • Uterine Neoplasms / mortality*
  • Uterine Neoplasms / pathology


  • Biomarkers, Tumor